Published in PLoS One on December 03, 2013
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer (2012) 5.15
Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell (1997) 3.48
Biology of interleukin-10. Cytokine Growth Factor Rev (2010) 3.41
Fatty acid synthase and cancer: new application of an old pathway. Cancer Res (2006) 3.37
Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care (2006) 3.09
IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J (1998) 2.99
Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A (1992) 2.92
Biology and action of colony--stimulating factor-1. Mol Reprod Dev (1997) 2.52
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res (2004) 2.43
Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res (2006) 2.37
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer (2009) 2.05
Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (2010) 2.00
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood (2008) 1.95
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res (2008) 1.92
Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem (1984) 1.69
Diverse bacteria promote macrophage foam cell formation via Toll-like receptor-dependent lipid body biosynthesis. J Atheroscler Thromb (2011) 1.57
The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol (1992) 1.55
Inflammation and immune surveillance in cancer. Semin Cancer Biol (2011) 1.41
Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol (2010) 1.38
Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood (2002) 1.37
Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci U S A (2010) 1.35
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives. Biochim Biophys Acta (2009) 1.33
Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab (2010) 1.27
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2007) 1.25
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer (2008) 1.25
Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem (1996) 1.23
Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem (2000) 1.20
Azithromycin alters macrophage phenotype. J Antimicrob Chemother (2008) 1.18
Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun (1999) 1.15
Inhibition of human macrophage colony formation by interleukin 4. J Exp Med (1989) 1.10
TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci (2000) 1.04
Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin Invest Med (1999) 0.99
Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7. J Immunol (1993) 0.96
Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages. Immunol Lett (2010) 0.93
Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation. Chem Biol Interact (2012) 0.91
Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomed Pharmacother (2011) 0.90
Effect of alcoholic extract of Ayurvedic herb Tinospora cordifolia on the proliferation and myeloid differentiation of bone marrow precursor cells in a tumor-bearing host. Fitoterapia (2005) 0.88
Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts. Growth Factors (1993) 0.88
M-CSF induces monocyte survival by activating NF-κB p65 phosphorylation at Ser276 via protein kinase C. PLoS One (2011) 0.88
Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol (1995) 0.87
Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L). Exp Mol Med (2002) 0.87
Human hematopoietic stem/progenitor cells overexpressing Smad4 exhibit impaired reconstitution potential in vivo. Blood (2012) 0.84
Immune predictors of cancer progression. Immunol Res (2012) 0.84
A mechanism of transcriptional regulation of the CSF-1 gene by interferon-gamma. Immunol Invest (2004) 0.83
Chemotherapy-induced myelosuppression. Semin Oncol Nurs (1992) 0.82
Role of host's antitumor immunity in exercise-dependent regression of murine T-cell lymphoma. Comp Immunol Microbiol Infect Dis (2005) 0.82
Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules. Biochim Biophys Acta (2012) 0.82
The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells. Int J Oncol (2012) 0.82
Differences in the inflammatory response induced by acute pancreatitis in different white adipose tissue sites in the rat. PLoS One (2012) 0.82
Pro- and anti-inflammatory control of M-CSF-mediated macrophage differentiation. Immunobiology (2010) 0.81
Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression. Crit Rev Oncol Hematol (1992) 0.81
Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. Biochimie (2011) 0.80
Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype. Biochim Biophys Acta (2013) 0.80
Macrophage function activating cytokines: potential clinical application. Crit Rev Oncol Hematol (1993) 0.80
Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J Reprod Immunol (2007) 0.79
Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol Lett (2000) 0.79
Inhibition of GM-CSF production by recombinant human interleukin-4: negative regulator of hematopoiesis. Leuk Lymphoma (1995) 0.78
Effect of aspirin administration on reversal of tumor-induced suppression of myelopoiesis in T-cell lymphoma bearing host. Blood Cells Mol Dis (2012) 0.78
Cytokine therapy. Adv Exp Med Biol (2012) 0.78
Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 1. Alterations in the CD4/CD8 distribution in thymocytes. Tumour Biol (2000) 0.78
α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton's lymphoma cells: role of altered cell survival-regulatory mechanisms. Anticancer Drugs (2013) 0.77
Gangliosides derived from a T cell lymphoma inhibit bone marrow cell proliferation and differentiation. Int Immunopharmacol (2001) 0.77
Macrophage effector mechanisms in melanoma in an experimental study. Arch Surg (2001) 0.77
Utilisation of fatty acid and triacylglycerol by rat macrophages: the effect of endotoxin. Cell Physiol Biochem (2002) 0.77
Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Anticancer Drugs (2008) 0.76
Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. Toxicol Appl Pharmacol (2012) 0.76
Management of myelosuppression in the patient with cancer. Oncol Nurs Forum (1990) 0.76